Call:
86-27-6552 3378
or
Contact Us
Login
|
Register
Home
About us
Company information
Photo albums
Privacy statement
News
Abebio News
Biological News
Promotions
Products
ELISA Kits
Proteins
Antibodies
Nucleic Acid Extraction Kits
Exosome Extraction Kits
IVD Raw Material
Service
Protein Service
Antibody Service
Kit Service
Technical support
FAQs
Catalog/Brochures
Terms and Conditions
Publications
Contact
Contact us
NEWS
Abebio News
Biological News
Promotions
Current Position:
Home
>>
News
>>
Biological News
Search articles:
News
TNF inhibitor failed to improve severe hand osteoarthritis
WASHINGTON, DC - Adalimumab, a tumor necrosis factor (TNF) inhibitor commonly used to treat rheumatoid arthritis (RA), failed to improve severe hand osteoarthritis (OA) in a randomized, double-blind, placebo-controlled trial, researchers reported at here ACR.
Read More
02
Sep,2020
Disease Mutations And The Parkin Protein
Researchers at the MRC Laboratory of Molecular Biology in the United Kingdom have determined the crystal structure of Parkin, a protein found in cells that when mutated can lead to a hereditary form of Parkinsons disease.
Read More
02
Sep,2020
Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism
Growth differentiation factor 15 (GDF-15), a marker of inflammation and oxidative stress, has emerged as a biomarker for arterial cardiovascular disease.
Read More
02
Sep,2020
Hereditary alpha tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis
Mastocytosis is a hematopoietic neoplasm characterized by expansion of KIT D816V-mutated clonal mast cells in various organs and severe or even life-threatening anaphylactic reactions.
Read More
02
Sep,2020
Researchers identify RNA molecule that helps lung cancer cells evade immune system
Researchers in Spain have identified a non-coding RNA molecule that helps lung cancer cells proliferate and avoid being killed by the bodys immune cells.
Read More
31
Aug,2020
Beating HIV and COVID-19 may depend on tweaking vaccine molecules
Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune system could potentially recognize and attack. So scientists must carefully consider which antigens should go into a vaccine.
Read More
31
Aug,2020
[1]
...
[<<]
-
[<]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
[29]
[30]
[>]
-
[>>]
...
[50]
We use cookies to make our site as useful as possible
. Our
Cookie Policy
explains how you can opt-out of the cookies we use. If you continue without changing your cookie settings, we'll assume you're happy with this.
Accept Cookies